To further evaluate the effects of MCU−/−ΔN as a potential therapeutic target in epilepsy, we additionally used an in vitro hyperexcitability model (low Mg2+ model) to test our hypothesis of potential protective MCU deficiency due to reduced ROS levels. Here, MCU is linked to epilepsy.